1. Introduction
Oxidative stress and inflammation are pathophysiological processes that usually accompany various chronic diseases [1]. Oxidative stress and inflammatory processes are intertwined and affect each other through the activation of a plethora of molecular pathways. Oxidative stress promotes the prognosis of many diseases including inflammation, metabolic and liver diseases. The antioxidant scavenging process is an important process to prevent the harmful effect of free radicals [2]. Recently, nuclear factor erythroid 2-related factor 2 (NRF2), an antioxidant and cytoprotective factor, has received great attention because it exhibits interesting anti-inflammatory and hepatoprotective effects [3]. The uncontrolled generation of superoxide anions by human neutrophils plays a crucial role in the development of inflammatory and autoimmune disorders related to oxidative stress [4]. Thus, the use of drugs with antioxidant and/or anti-inflammatory activity is necessary to treat many oxidative stress-related diseases [5]. Most of the used antioxidants are of natural origin such as phenolics and vitamins. Phenolics are widely distributed in the plant kingdom. They can be found in many foods and medicinal plants and possess potent antioxidant properties rendering them ideal candidates for the development of antioxidant drug leads [6].
Iris L. (Iridaceae Juss.) is one of the largest genera of perennial herbaceous plants that comprises 1800 species [7]. Iris sp. are distributed in Europe, northern Africa, Asia, and the Middle East [8]. Rhizomes of various Iris sp. (I. germanica L., I. pallida Lam., and I. florentina L.) serve as a source of essential oils, which are widely used in cosmetics and perfumery [9]. The underground parts of several Iris sp. have been used in traditional European medicine for centuries [10]. Purified and dried rhizomes of I. germanica, I. florentina, or I. pallida are collectively known as Rhizoma iridis. They are commonly used because of their cathartic, emetic, stimulant, and expectorant properties. Dry rhizomes were used as an ingredient in tooth powders and as a chewing agent to promote teething in children. I. germanica is used to treat liver and spleen diseases in traditional medicinal systems [11].
Previous chemical and pharmacological studies on Iris sp. indicated that the plants contain several classes of secondary metabolites such as flavonoids, isoflavones, and their glycosides, C-glucosylxanthones, quinones, triterpenoids, and stilbene glycosides [12,13,14]. These compounds contribute to the observed immunomodulatory [15,16], estrogenic [17,18], antioxidative [19,20,21], antibacterial [22,23] and anticholinesterase [24], cytotoxic [11,25], and anti-osteoporotic activities [26]. Experimental results indicate a direct correlation between Iris phenolic compounds (hydroxycinnamic acids, isoflavones, flavones, xanthones) and their pharmacological activity, especially the antioxidant activity [20,27,28,29].
The global distribution of Iris sp. along with their potent biological activities have encouraged many research groups to study their metabolic profiles. Several reports have discussed the isolation and purification of new isoflavones from Iris rhizomes [25,30,31,32,33]. Scientists had to purify the new compounds using tedious chromatographic techniques and to identify the structures of the compounds using several spectroscopic techniques. These techniques are time-consuming, labor-intensive, and use excessive amounts of solvents [34,35]. Since the 1990s, new methods were developed to provide a direct approach to identify plant constituents in complex herbal extracts.
Liquid chromatography (LC) coupled with MS/MS facilitates the characterization of various compounds based on the molecular formula, exact mass, and fragmentation pattern [36,37]. HPLC-DAD-ESI-MS/MS was used for the qualitative identification of the main constituents in the rhizomes of I. crocea, I. germanica, and I. spuria from Kashmir (India) [38]. This method showed high sensitivity and allowed the identification of substances present in the raw materials in minor quantities. Sajad et al. developed an HPLC-UV-DBP method for the rapid identification and quantification of tectorigenin in Iris sp. growing in Kashmir [39]. The quantitative determination of tectorigenin indicated its presence in 1.08% to 8.84%. In another study, HPLC–DAD–CL and HPLC–ESI-Q-TOF-MS/MS were used for the identification of xanthones, isoflavonoid glycosides, and their aglycones, flavones, and other phenolic compounds in the rhizomes of Belamcanda chinensis (I. domestica), I. tectorum, and I. dichotoma grown in China [27]. However, most of these methods allowed the qualitative or quantitative determination of one or a few compounds but failed to present the full metabolic profile of the plants of interest.
In the last few years, several groups have used HPLC-DAD-ESI-MSn for the identification of the metabolic profile of several medicinal plants [40,41,42]. This method was used by Wei et al. for the identification of known isoflavones in the rhizomes of I. tectorum and I. dichotoma grown in China. HPLC-DAD-ESI-MSn can simultaneously provide UV and mass spectra, necessary for the identification of known components by comparing the chromatographic data of authentic compounds to the on-line detected chromatograms of the target compounds. It provided fragmentation pathways of the known compounds that can assist in elucidating the unknown structures based on the tandem mass [27,28,43]. Currently, HPLC coupled with several detectors is the optimal chromatographic method for the quick, simple, and quantitative identification of secondary metabolites in plant extracts [44]. Our previous phytochemical investigations on Iris sp. resulted in the isolation of flavones, isoflavones, xanthones, hydroxycinnamic acids, and coumarins by column chromatography. However, the qualitative and quantitative determination of phenolic compounds in certain Iris sp. using HPLC was never carried before. Thus, this study aimed to qualitatively and quantitatively compare the phenolic compounds in the rhizomes of four Ukrainian Iris sp. (I. pallida, I. hungarica, I. sibirica, I. variegata) by HPLC-DAD and UPLC-MS/MS. Furthermore, we analyzed the samples’ antioxidant capacity using the HPLC-ABTS system and NRF2 expression for the first time. We also conducted related pharmacological in vitro assays for I. hungarica and I. variegata crude extracts, including anti-inflammatory, anti-allergic, cytotoxic, hepatoprotective, and human coronavirus 229E (HCoV-229E) bioassays.
2. Results and Discussion
2.1. Optimization of the HPLC-DAD and UPLC–MS/MS Conditions
In the current research, we applied certain modifications to an HPLC method developed for the simultaneous determination of phenolic compounds in the rhizomes of I. dichotoma [41]. The applied modifications resulted in a better separation of compounds with good peak symmetry. In our study, we used methanol as the extraction solvent and an ultrasonic bath to enhance the extraction efficacy. Chromatographic separation of the extracts was carried out using a Shimadzu HPLC system equipped with an ACE C18 column. Gradient elution was applied with 0.1% acetic acid in water-acetonitrile and acetonitrile with increasing polarity from 5% to 95%. Similar polyphenolic compounds were detected in the extracts of I. pallida, I. hungarica, I. sibirica, and I. variegata rhizomes as demonstrated by HPLC-DAD and UPLC–MS/MS analyses. Compound identification was based on their co-elution with reference compounds previously isolated from the rhizomes of I. pseudacorus [45] and I. hungarica [13,46,47], as well as based on the UV/MS spectroscopic data. For the qualitative analysis of phenolic compounds, a more selective and sensitive negative ionization mode method was selected for the crude plants [48].
2.2. Validation of the Methodology
The developed method was fully validated. The calibration curve, limits of detection (LOD), limits of quantification (LOQ), and the linear range for each analyte are provided in Table 1. All compounds showed good linearity (r2 ≥ 0.9993) within the tested ranges. The repeatability was expressed as the relative standard deviation (%RSD) of the major constituents’ content and the RSD ranged from 0.3% to 1.3%, which was satisfactory. The determination of the main compounds in the tested solutions was done by comparing the peaks retention times and the UV-spectrum obtained from the chromatogram of the standard solution (Table 2 and Table S1). All results revealed repeatability, accuracy, high sensitivity and good linearity of the method.
2.3. Qualitative Analysis of the Samples
The retention times and fragmentation pattern of the investigated compounds [M − H]− in the negative mode (MSn spectra) were compared with the spectra of the standards. Eleven peaks were thus identified, including gallic acid (1), mangiferin (2), caffeic acid (3), tectoridin (4), germanaism B (or nigricin 4′-O-β-
Compound 1 was identified as gallic acid according to the absorbance maxima at 217 nm and 271 nm, characteristic of the hydroxycinnamic group of compounds. The presence of a molecular ion at m/z 169 further confirmed its nature [49]. Gallic acid is formed through the shikimic acid pathway and is a major component of many phenolic compounds [50]. Compound 3 also showed absorbance maxima at 236 nm and 324 nm corresponding to the hydroxycinnamic group of the compound. Compound 3 was eluted at tR 3.92 min and showed fragment ions at m/z 179, 161, and 135 in the negative-ion mode, suggesting a caffeic acid structure. It is known that caffeic acid possesses potent antioxidant, anti-inflammatory, and antineoplastic properties [51,52] so its presence in the Iris raw materials supports their use in folk medicine targeting inflammatory-related disorders.
Compound 2 showed typical maximum absorption peaks at 240 (shoulder peak), 257, 318, and 365 nm, which are characteristic UV features of xanthones (mangiferin). Compounds 4–11 demonstrated maximum absorption peaks at 218–322 nm (shoulder peak) and 218–264 nm which are characteristic peaks of isoflavones (Table S1). MS data were measured in the negative ion mode and the mass spectroscopic data of all compounds are listed in Table 3. The detected compounds demonstrated regular MS fragmentation behavior, which was useful in providing information on their chemical structures. For the flavonoid glycosides, the MS spectra showed an ion at m/z [(M–H) − 120]− which represents a characteristic ion of C-glycosides, such as mangiferin (2). Mangiferin was the only C-glycosidic xanthone derivative identified in Iris sp. by this method. The MS spectra of flavonoid glycosides exhibited a loss of 162 Da, suggesting the presence of one hexose residue. This fragmentation pattern was characteristic of O-glycosides, such as tectoridin (4) and irisolidone-
In a previous report, tectoridin was identified in I. crocea and I. tectorum rhizomes by HPLC-DAD-ESI-MS/MS [38]. The presence of mangiferin and irigenin in I. germanica rhizomes was also demonstrated by the same authors. Also, isoflavonoids such as mangiferin, tectoridin, tectorigenin, irigenin, iristectorin A, iristectorin B, iridinirisflorentin, dichotomitin, and irilone were identified in the rhizomes of I. dichotoma grown in China [27]. However, the quantitative analysis of these compounds was never carried out. In the current investigation, gallic acid was only identified in I. variegata and I. hungarica rhizomes, while caffeic acid was observed in all analyzed samples.
Mangiferin is the most widespread C-glycosylxanthone in Iris sp. [53]. It was identified in 47 Iris sp. and subspecies, whereas its isomer isomangiferin was detected in 41 species [54]. Mangiferin possesses a chemotaxonomic value for Iris plants on the tribe, subgenus, section, and series levels. The Irideae and Tigrideae tribes may be distinguished from other Iridaceae tribes by the presence of mangiferin. In general, isoflavones were detected as the major components and could be considered as chemotaxonomic markers for these Iris sp.
2.4. Quantitative Analysis of the Samples
To estimate the potential pharmacological activities of the examined raw material, comparative quantitative analysis of each of the phenolic compounds content was carried out. The results of the HPLC quantitative analysis of the phenolic compounds in the rhizomes of each Iris sp. are presented in Table 4.
According to our results, I. sibirica rhizome extract can be distinguished from other extracts by having low amounts of phenolic compounds. The amounts of mangiferin (2) (0.267 ± 0.002 mg/g) and caffeic acid (3) (0.288 ± 0.012) were the highest among other identified compounds in this Iris rhizome. However, the content of all compounds including tectoridin (4) (0.038 ± 0.001 mg/g), germanaism B (5) (0.012 ± 0.000 mg/g), irisolidone-
Studies on I. pallida from Ukraine indicated that it does not contain a high quantity of phenolic compounds compared with other species. According to the published data [55], this species contains isoflavones irigenin, iristectorigenin A, nigricin, nigricanin, irisflorentin, iriskumaonin methyl ether, irilone, iriflogenin, and cis- and trans-α-irone. In the current investigation, high amounts of irigenin (9) (3.199 ± 0.034 mg/g) and tectoridin (4) (1.642 ± 0.023 mg/g) were detected. According to our knowledge, tectoridin, germanaism B, irisolidone-
The amounts of germanaism B (5) and irisolidone-D-glucoside (6) were the highest in the methanolic extracts of I. variegata and I. hungarica rhizomes (7.089 to 6.285 mg/g and 7.507 to 7.353 mg/g, respectively). The concentrations of irigenin (9) (5.518 ± 0.031 mg/g) and xanthone mangiferin (2) (5.747 ± 0.080 mg/g) in I. variegata were also high in comparison with the other tested Iris sp. According to the conducted HPLC analysis, every Iris sp. contained mangiferin with its amounts varying from 0.267 (I. sibirica) to 5.747 mg/g (I. variegata). These amounts were higher compared with the previous reports. For example, the amount of mangiferin in I. dichotoma rhizomes from different regions in China was 0.86–2.03 mg/g which was almost three times less compared with I. variegata from Ukraine [41]. Mangiferin has a wide range of pharmacological activities such as antiviral [56], antitumor, immunomodulating [57], antioxidant [58], and antituberculosis effects [59], thus its identification and quantification in Iris raw materials are important from a therapeutic perspective. Among hydroxycinnamic acids, gallic acid (1) was found in the extracts of I. variegata (3.729 ± 0.134 mg/g) and I. hungarica (2.362 ± 0.076 mg/g).
The most common isoflavonoid-O-glucosides in I. hungarica rhizomes were tectoridin (4), germanaism B (5), irisolodone-
To the best of our knowledge, there was no previous report on the qualitative and quantitative determination of isoflavones such as iristectorigenin B, germanaism B, irisolidone-D-glucoside, its aglycone, nigricin, and 5,6-dihydroxy-7,8,3′,5′-tetramethoxyisoflavone in Iris raw materials. In a previous study, 5,6-dihydroxy-7,8,3′,5′-tetramethoxyisoflavone (10), a new natural compound, was isolated from I. pseudacorus [41]. In the current study, this compound was also identified in the other Iris sp. Its amount varied from 1.056 ± 0.002 mg/g in I. hungarica, 0.457 ± 0.003 mg/g in I. pallida to the highest amount (1.512 ± 0.013 mg/g) in I. variegata. Caffeic acid (3) was found in all species with the amount ranging from 0.227 to 1.515 mg/g, and the highest content was detected in I. hungarica rhizomes.
Out of the eleven compounds, 2, 3, 4, 5, 6, 8, and 9 were identified in all Iris sp., irisolidone-
According to the results of the qualitative and quantitative analysis of the phenolic antioxidant compounds in Iris sp. growing in Ukraine, it can be concluded that these plants were not inferior to Iris sp. grown in other places around the globe. The presence and high content of phenolic compounds in I. variegata and I. hungarica encouraged us to subject these two species to intensive pharmacological investigations.
2.5. Pharmacology Investigation of I. variegata and I. hungarica Extracts
Phenolic compounds are known to act as antioxidants with beneficial effects on various diseases. Phenolics can prevent the development of cardiovascular diseases, cataracts, cancers, reduce fat absorption, and positively affect metabolism [62]. The potential antioxidant capacity, as well as other pharmacological activities of Iris rhizomes crude extracts, were evaluated in several bioassays reflecting the traditional use of Iris rhizomes against infection, liver, and inflammatory diseases.
2.5.1. Antioxidant Activity
The HPLC-ABTS co-elution system represents a convenient method to analyze the antioxidant components in the plant crude extract [63]. The radical scavenging activities, which were expressed as Trolox equivalent antioxidant capacity (TEAC), varied among the Iris rhizomes water and ethanol extracts (Table 5). The antioxidant activity of I. variegata water extracts was the lowest (TEAC 2.92 ± 0.07 µmol/g) (Figure 4a). On the other hand, I. hungarica showed a potent antioxidant capacity for the water extract (TEAC 23.11 ± 0.90 µmol/g) (Figure 4b), and the ethanol extract showed the highest total antioxidant capacity (TEAC 50.32 ± 1.09 µmol/g) (Figure 4c). The antioxidant activity of the identified compounds (TEAC values, Trolox µmol/g) is displayed in Table 5. The extracts possessed antioxidant activity due to the presence of gallic acid, mangiferin, and caffeic acid. This can be explained by the fact that phenolic compounds are potent antioxidants [50,64,65] due to their high redox potential allowing them to become hydrogen donors and singlet oxygen quenchers [66]. The established antioxidant activity of the extracts was correlated with the content of the identified compounds. The higher the content of mangiferin, caffeic acid, and gallic acid, the higher the antioxidant activity (Figure 4). Higher amounts of mangiferin in I. hungarica together with gallic acid in the ethanolic extract accounted for more potent antioxidant capacity of the plant extract in comparison with water extracts. The obtained results were in good agreement with the previous studies [28,37].
2.5.2. Anti-Inflammatory Activity of Iris sp. Extracts against Respiratory Burst and Degranulation by Human Neutrophils
The respiratory burst and degranulation of neutrophils are important processes in the maintenance of human health, but they need careful regulation to prevent the development of chronic and auto-immune diseases. Superoxide is a major radical produced by neutrophils and its excessive amount contributes to several acute and chronic diseases, including lung injury, sepsis, or arthritis [4]. We evaluated the effects of Iris extracts on superoxide anion generation and elastase release triggered by fMLF in CB-primed human neutrophils. The results revealed that the water extracts of I. variegata and I. hungarica rhizomes showed anti-inflammatory potential and inhibited superoxide anion generation at 10 μg/mL by 41.0% and 45.7%, respectively (Table 6). Interestingly, both the ethanolic and water extracts of I. hungarica rhizomes showed enhancing effects on elastase release by human neutrophils and thus may have immune-promoting effects related to degranulation. The observed effects of Iris water extracts may be correlated to the abundant isoflavone content.
2.5.3. Antioxidant Capacity Expressed as NRF2 Activity
Nuclear factor erythroid 2-related factor 2 (NRF2) is a nuclear transcription factor usually activated in response to reactive oxygen species (ROS). NRF2 increases the antioxidant capability of all cells in response to stress, thus its activation is beneficial for health. It is also known that the level of NRF2 indicates the antioxidant capacity of the cells and its increase is linked with the enhanced ability to scavenge radicals [67]. Plants phenolic rich extracts were previously shown to exert a cytoprotective effect by increasing heme oxygenase-1 (HO-1) together with NRF2 [68]. In the current study, NRF2 activity was evaluated in HacaT normal skin cell line. I. variegata rhizomes showed a mild enhancing effect on NRF2 activity by 72.7% in normal skin cells indicating cytoprotective effects (Table 7), however, the effect did not correlate with the phenolics content (Section 2.5.1).
2.5.4. Assessment of the Anti-Allergic Activity by the Inhibition of RBL-2H3 Cells Degranulation
The incidence of allergic diseases is dramatically increasing and the search for new drugs from natural sources is of great importance. We used a degranulation assay to evaluate the anti-allergic effect of Iris sp. To ascertain non-false positive effects of the samples that could be caused by the inhibition of cell viability, all samples were evaluated for toxicity against RBL-2H3 (rat basophilic leukemia cells) using MTT viability assay. The samples were found to be nontoxic (viability was over 96% compared with the control) at 100 μg/mL (Table 8). Samples were then evaluated for the anti-allergic activity using degranulation assay (β-hexosaminidase release detection assay) induced either by calcium ionophore (A23187) or antigen (anti-DNP IgE plus DNP-BSA). Calcium ionophore serves as a direct activator by facilitating calcium influx into the cell, while antigen mimics the physiological conditions of IgE-antigen complex binding to the FcεRI receptor on the mast cell membrane [69]. The results revealed that the water extract of I. variegata rhizomes (100 μg/mL) inhibited the degranulation of mast cells stimulated by A23187 or antigen with 38.3% and 27.0%, respectively, and the ethanolic extract of I. hungarica rhizomes (100 μg/mL) 22.0% and 46.7%, respectively (Table 8). Dexamethasone, a positive control, inhibited A23187- or antigen-induced β-hexosaminidase release by 65.7% and 66.3%, respectively.
2.5.5. Cytotoxic Activity of Iris sp. Extracts
I. variegata and I. hungarica rhizomes aqueous extracts reduced the viability of melanoma (IGR39) (IC50 0.53 and 1.15 mg/mL, respectively) and triple-negative breast cancer (MDA-MB-231) (IC50 0.33 and 0.57 mg/mL, respectively) cell lines (Figure 5). I. hungarica rhizomes 70% ethanolic extract showed comparable efficacy to I. variegata water extract. Amin et al. established similar EC50 values for the methanolic extract of I. kashmiriana rhizomes from Kashmir against epithelial cancer cell lines including lung cancer A549 (IC50 0.13 mg/mL) and colon cancer Caco-2: (IC50 0.24 mg/mL) [70].
All extracts demonstrated lower activity against melanoma cells. Triple-negative breast cancer cells were 1.5–2 times more sensitive. It is a very interesting finding, as these cells do not possess receptors for estrogen, progesterone, and HER-2 receptors, and are usually characterized by a more aggressive nature compared with other cancer cell lines [71]. Comparing the cytotoxic effect of the aqueous and ethanolic extracts obtained from I. hungarica rhizomes, ethanolic extract was more effective against both melanoma (IGR39) and triple-negative breast cancer (MDA-MB-231) cells.
2.5.6. Lipid Formation Activity
Non-alcoholic fatty liver disease is a common liver disease caused mainly by obesity and metabolic syndrome [72]. Lipid droplets are intracellular fat storage organelles found in most cells and are essential for all organisms. Dysregulated accumulation of lipids in cells leads to many health disorders including non-alcoholic steatohepatitis (fatty liver), obesity, type 2 diabetes, and even facilitates hepatitis type C virus infection [73]. Lipid droplets formation plays a role not only in the fatty liver but also in the process of atherosclerosis, where triacsin C, the long-chain fatty acyl CoA synthetase inhibitor, demonstrated profound effects [74]. According to our results, the water extract of I. hungarica rhizomes showed a 35.1% inhibitory effect on the lipid droplets in Huh7 liver cells (Table 7).
Iris plants are rich in isoflavonoids and xanthones, which possess a wide range of biological activity, including anti-inflammatory, antioxidant, and antitumor properties. Phytochemical and pharmacological studies provide new insights into the possible therapeutic uses of these plants.
2.5.7. Human Coronavirus 229E Activity
Human coronavirus 229E (HCoV-229E) is a strain of coronavirus family viruses, that causes upper respiratory syndrome [75]. In the screening for anti-coronavirus activity, I. hungarica and I. variegata did not show any protective effects against human coronavirus 229E (HCoV-229E) infection at 10 μg/mL (Figure 6).
3. Materials and Methods
3.1. Chemicals and Reagents
Nine reference compounds, including mangiferin, nigricin, germanaism B, irisolidone-7-O-β-
3.2. Plant Materials
The rhizomes of I. hungarica Waldst. et Kit., I. pallida Lam., I. sibirica L. and I. variegata L. were obtained from the collections of M.M. Gryshko National Botanical Garden of the National Academy of Sciences of Ukraine (Kyiv, Ukraine) in October 2018. They were identified and authenticated by Dr. Buidin (Department of the Ornamental Plants, National Botanical Garden). Voucher specimens (CWN0056548, CWN0056549, CWN0056545, CWN0056534) were identified by Dr. Gamulya and were deposited at Herbarium of V.M. Karazin Kharkiv National University (Kharkiv, Ukraine).
3.3. Sample Preparation
The air-dried materials were ground to a fine powder using a laboratory mill. The powdered materials of Iris rhizomes (0.1 g, 60 mesh) were weighed into a volumetric flask, and methanol (10 mL) was used for extraction. The flask was placed in an ultrasonic bath at room temperature (20 ± 2 °C) for 30 min. The solutions were filtered through a membrane filter (0.45 μm) into vials made of glass. An aliquot of 20 μL was injected twice into the HPLC system for analysis. The reference compounds were used to prepare the standard solutions at a concentration of 1.0 mg/mL in methanol and were used for calibration. The samples were stored at 4 °C before use.
3.4. HPLC Conditions
The separation of phenolic compounds was carried out using an ACE C18 column (250 mm × 4.6 mm, 5.0 μm; Zorbax Eclipse Plus, Agilent, Santa Clara, CA, USA). The flow rate of elution was 1 mL/min. The solvent system comprised solvent A (0.1% acetic acid in water) and solvent B (acetonitrile). An ultrasonic bath was used for degassing, then all solvents were filtered using a filter with a 0.22 μm membrane. A linear gradient program was applied: 0–8 min, 5–15% B; 8–30 min, 15–20% B; 30–48 min, 20–40% B; 48–58 min, 40–50% B; 58–65 min, 50%; 65–66 min, 50–95% B. The temperature of the column was constant at 25 °C. The injection volume of the sample solution was adjusted at 20 μL. The chromatograms were recorded at 269 nm (Figure 1).
3.5. Chromatographic Conditions for the UPLC-MS Method
Separation of the samples’ components was carried out with the ACQUITY H-class UPLC system (Waters, Milford, MA, USA) equipped with ACQUITY UPLC BEH C18 (50 × 2.1 mm, particle size 1.7 µm) (Merck Millipore, Darmstadt, Germany). Gradient elution was performed with 0.1% formic acid water solution (solvent A) and acetonitrile (solvent B), the flow rate at 0.5 mL/min. The following proportions of the solvent system were applied using a linear gradient profile B: Initial 5%, 3 min. 30%, 7 min. 50%, 7 to 8 min. 95%, 15 to 16 min. 5%. Xevo TQD triple quadrupole mass spectrometer detector (Waters) was used to obtain MS/MS data. Positive electrospray ionization was applied with the following settings: Capillary voltage was 1.5 kV, source temperature was 150 °C, desolvation temperature was 350 °C, with a desolvation gas flow 650 l/h, cone gas flow was 25 l/h. Collision energy and cone voltage were optimized for each compound separately. Collision energy varied in the range from 6eV to 20 eV and cone voltage was selected from 8 V to 38 V.
3.6. Identification of the Peaks and Peak Purity
The identification of the compounds 1–11 was achieved by HPLC analysis. The retention time (Rt), UV, MS/MS spectra of the peaks in the samples were compared with those of the authentic reference compounds. The purity of the compounds was evaluated by a diode array detector coupled with the HPLC system. The UV spectra of each peak were compared with those of the authentic reference compounds and/or by assessment of the MS/MS spectra.
3.7. Quantitative Determination of the Constituents
The compound concentration in the plant extract was calculated (mg/g) by the following formula:
(1)
where S—phenolic compound peaks average area calculated from the parallel chromatograms of the sample solution; Sst—reference compound peaks average area calculated from the parallel chromatograms of the standard solution; m—powdered raw materials weights in g; mst—reference compound weights in mg; V—volumetric flask volume of the test extract in mL and Vst—volumetric flask volume of the reference compounds in mL. The results are summarized in Table 4.3.8. Quantitative Analysis Validation Procedures
Following the United States Pharmacopeia (USP) recommendations, there are various analytical method validation parameters, including the limit of quantification (LOQ), the limit of detection (LOD), linearity, accuracy, and repeatability [76]. The responses’ linearity range of the standards was obtained using ten concentration levels with two injections for each level. The seven analytes were dissolved in methanol and the stock solutions were prepared. The stock solutions were diluted to a series of appropriate concentrations to construct the calibration curves. All calibration curves were recorded using the solutions of the reference compounds with an injection volume of 2.2 µL. The working solution with the lowest concentration was diluted with methanol to various concentrations. These solutions were then used for the determination of the limits of detection (LOD) and limits of quantification (LOQ) at a signal-to-noise ratio (S/N) of 3 and 10 for each compound. The repeatability was evaluated by analyzing six replicates of each preparation using HPLC (repeatability on the real sample). The main peak areas of two repeated chromatograms were used to calculate the relative standard deviation (RSD). The results are presented in Table 1 and Table 2.
3.9. HPLC-PDA Conditions and HPLC Post-Column Assay
HPLC-PDA and HPLC-ABTS were done using a Waters Alliance 2695 separation module system as previously described by Marksa et al. with some modifications [77]. Details are described in the Supplementary Materials section.
3.10. Instruments
Separation of the compounds was achieved using a Nexera X2 LC-30AD HPLC system (Shimadzu, Kyoto, Japan). The system comprises an on-line degasser, a quaternary pump, SIL-30AC autosampler (Shimadzu), CTO-20AC thermostat (Shimadzu), a column temperature controller and a SPD-M20A diode array detector (DAD). Other instruments used in the investigation were an Ultrasonic Cleaner Set (Wise Clean WUC-A06H, Witeg Labortechnik GmbH, (Wertheim Germany), Libra UniBloc AUW120D (Shimadzu Analytical Scale, Kyoto, Japan); pH-meter—Knick Electronic Battery-operated pH Meter 911 PH (Portamess, Berlin, Germany), and class A analytical vials that meet requirements of the State Pharmacopoeia of Ukraine (SPhU, 2015).
3.11. Extraction Procedure of Iris sp. for Bioassay
I. variegata and I. hungarica rhizomes were dried, ground, and the powder was extracted with distilled water in a water bath at 100 °C (100 g, 1 L, 60 min × 3) or 70% ethanol at room temperature (100 g, 1 L, 60 min × 3). The extracts were concentrated to dryness.
3.12. In-Vitro Assessment of NRF2 Activity
The activity of NRF2 reporter cells was evaluated [78]. The cell line HaCaT/ARE (antioxidant response element) was developed using a HaCaT stable cell line carrying a fragment derived from pGL4.37[luc2P/ARE/Hygro] plasmid and the luciferase reporter gene luc2P. Details are described in the Supplementary Materials section.
3.13. Lipid Droplet Assay
Lipid droplet assay was performed by treating Huh7 cells with BSA-conjugated oleic acid as described previously [72]. The details are described in the Supplementary Materials section.
3.14. Assessment of Anti-Allergic Activity Using In Vitro Assay
A methylthiazole tetrazolium (MTT) assay [79] was used to measure the possible toxic effects of the samples on RBL-2H3 cells and the experiment was performed as previously described [80]. β-Hexosaminidase activity assay was used to determine the degree of A23187-induced [81,82] and antigen-induced [83] degranulation in RBL-2H3 cells as previously described. The details of the assays are presented in the Supplementary Materials section.
3.15. Assessment of Anti-Inflammatory Activity Using In Vitro Assay
Blood was taken from healthy human donors using a protocol approved by the Chang Gung Memorial Hospital review board. Neutrophils were isolated according to the standard procedure described before [84]. The inhibition of superoxide anion generation was measured by the reduction of ferricytochrome c as previously described [85]. Elastase release representing the degranulation from azurophilic granules was evaluated as described before [86]. Details can be found in the Supplementary Materials section.
3.16. In Vitro Assessment of Cytotoxic Activity
The potential cytotoxic effect of Iris extracts on certain cell lines was determined by a MTT viability assay as described before [87]. Details can be found in the Supplementary Materials section.
3.17. Coronavirus 229E Assay
The protective effects of the samples against human coronavirus 229E (HCoV-229) was determined based on the previously described method [88]. The Huh7 cells line (human liver carcinoma cell line) was obtained from Dr. Rei-Lin Kuo (Chang Gung University, Taoyuan, Taiwan). The cells were infected with nine times the Median Tissue Culture Infectious Dose (TCID50) of each coronavirus 229E in the presence or absence of the compounds or vehicle. After incubation at 33 °C for 6 days, the surviving cells were then stained with MTT (3-[4.5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide). The percentage of surviving cells was then calculated.
3.18. Statistical Analysis
The processing of HPLC data was carried out using the LabSolutions Analysis Data System (Shimadzu). Statistical analysis was performed using one-way analysis of variance (ANOVA) followed by Tukey’s multiple comparison using Prism v.5.04 (GraphPad Software Inc., La Jolla, CA, USA, chemical composition), by Dunnet’s test (GraphPad Prism 6.0, GraphPad Software Inc., San Diego, CA, USA, anti-allergic assay), or Student’s t-test (SigmaPlot, Systat Software Inc., San Jose, CA, USA, anti-inflammatory assay). Values with p-values below 0.05 were considered statistically significant. The results were expressed as means ± SD (chemical analysis) or S.E.M (anti-inflammatory, anti-allergic, and antioxidant assays) values of at least three independent measurements unless otherwise specified. Two definitions were carried out in the chemical analysis.
4. Conclusions
In the present study, quantitative and qualitative analyses of the methanol extracts of four Iris sp. (I. pallida, I. hungarica, I. sibirica, and I. variegata) rhizomes were performed using a new HPLC method. Eleven phenolic compounds were identified. The identification was based on co-chromatography with reference compounds and UV/MS data. According to our analysis, mangiferin, tectoridin, germanaism B, irigenin, irisolidone-
Supplementary Materials
The following materials are available online, Figure S1: MS-chromatogram of I. hungarica, Figure S2: MS-chromatogram of I. variegata, Figure S3: MS-chromatogram of I. pallida, Figure S4: MS-chromatogram of I. sibirica rhizomes. Table S1: The specificity of eleven quantified compounds and their chemical structures. Details on the Methodology.
Author Contributions
Conceptualization, O.M. and M.K.; Data curation, O.M. and M.K.; Funding acquisition, L.I., V.G. and T.-L.H.; Investigation, O.M., M.K., V.P., C.-H.Y. and B.-H.C.; Methodology, O.M., M.K., L.I., V.P., G.-H.L., C.-Y.L., C.-H.Y. and B.-H.C.; Supervision, V.G. and T.-L.H.; Validation, I.B., A.M. and M.E.-S.; Visualization, O.M. and M.K.; Writing—original draft, O.M. and M.K.; Writing—review & editing, M.E.-S, V.G. and T.-L.H. All authors have read and agreed to the published version of the manuscript.
Funding
This research was funded by the grants from the Ministry of Science and Technology (MOST 106-2320-B-255-003-MY3, MOST 108-2320-B-255-003-MY3, MOST 108-2320-B-037-004, MOST 109-2327-B-255-001 and MOST 109-2327-B-182-002), Taiwan; Ministry of Education (EMRPD1G0231 and EMRPD1H0381), Kaohsiung Medical University (KMU-DK109002-3), Chang Gung University of Science and Technology (ZRRPF3H0101 and ZRRPF3H0111), and Chang Gung Memorial Hospital (CMRPF1F0011~3, CMRPF1F0061~3, CMRPF1G0241~3, CMRPF1J0051~3, and BMRP450), Taiwan.
Acknowledgments
The authors would like to thank the Head of the Department of the Ornamental plants, Senior Researcher of the M.M. Gryshko National Botanical Garden National Academy of Sciences of Ukraine (Kyiv), and Dr. Buidin for their help in the identification and characterization of the plants. The authors would like to thank the Center for Research Resources and Development, Kaohsiung Medical University for providing instrumentation support.
Conflicts of Interest
The authors declare no conflict of interest.
Abbreviations
ABTS | 2,2′-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt |
CB | cytochalasin B |
DMEM | Dulbecco’s modified Eagle’s medium |
DMSO | dimethyl sulfoxide |
DNP-BSA | dinitrophenyl-conjugated bovine serum albumin |
FBS | fetal bovine serum |
fMLF | formyl-methionyl-leucyl-phenylalanine |
HPLC-DAD | high-performance liquid chromatography coupled with diode array detector |
NRF2 | nuclear factor erythroid 2-related factor 2 |
RBL | rat basophilic leukemia |
UPLC-MS/MS | ultra-performance liquid chromatography coupled with tandem mass spectrometry |
Footnotes
Sample Availability: Samples of the compounds gallic acid, mangiferin, caffeic acid, tectoridin, germanaism B, irisolidone-7-O-β-
Figures and Tables
Figure 1. HPLC-DAD chromatograms recorded at 269 nm of the mixed reference compounds: Gallic acid (1), mangiferin (2), caffeic acid (3), tectoridin (4), germanism B (5), irisolidone-d-glucoside (6), iristectorigenin B (7), nigricin (8), irigenin (9), 5,6-dihydroxy-7,8,3′,5′-tetramethoxyisoflavone (10), and irisolidone (11).
Figure 2. The HPLC-DAD chromatograms of the methanolic extracts of I. pallida (A), I. hungarica (B), I. variegata (C), I. sibirica (D): Gallic acid (1), mangiferin (2), caffeic acid (3), tectoridin (4), germanism B (5), irisolidone-d-glucoside (6); iristectorigenin B (7), nigricin (8), irigenin (9), 5,6-dihydroxy-7,8,3′,5′-tetramethoxyisoflavone (10), and irisolidone (11).
Figure 3. UPLC-MS chromatograms of compounds in the negative ion mode: Gallic acid (1) (1.14 min), mangiferin (2) (4.21 min), caffeic acid (3) (3.92 min), tectoridin (4) (5.47 min), irisolidone d-glucoside (6) (6.95 min), iristectorigenin B (7) (7.53 min), irigenin (9) (7.62 min), 5,6-dihydroxy-7,8,3′,5′-tetramethoxyisoflavone (10) (8.19 min), and irisolidone (11) (8.47 min).
Figure 4. HPLC-ABTS chromatograms of (a) I. variegata rhizomes extract (H2O) at 247 nm (HPLC, black) and 650 nm (ABTS, blue); (b) I. hungarica rhizomes extract (H2O) at 255 nm/650 nm, and (c) I. hungarica rhizomes extract (70% EtOH) at 314 nm/650 nm. Gallic acid (1), mangiferin (2), and caffeic acid (3).
Figure 5. Cytotoxic effect of the tested extracts against melanoma (IGR39) and triple-negative breast cancer (MDA-MB-231) cell lines. I. variegata rhizomes water extract, I. hungarica rhizomes water extract and I. hungarica rhizomes ethanolic (70% EtOH) extract were tested. The values are expressed as EC50 values, indicating concentrations causing a 50% reduction in viability of the cells (n = 3).
Figure 6. Human coronavirus 229E (HCoV-229E) protective activity of Iris rhizomes extracts. The cells infected by HCoV-229E were treated with the samples (orange) or vehicle (grey), any difference between them would indicate protective effects against HCoV-229E infection. The uninfected cells were also treated with the samples (dark blue) or vehicle only (light blue), serving as a control for cell viability after the treatment with the samples or vehicle. I. var W, I. variegata rhizomes (water extract); I. hung W, I. hungarica rhizomes (water extract); I. hung EtOH, I. hungarica rhizomes (ethanolic extract).
Calibration curves, LOD, and LOQ data of eleven phenolic reference compounds.
Peak No | Compound | Calibration Curve a | Correlation Coefficient r2 (n = 6) | Linear Range (μg/mL) | RSD (%) | LOD b (ng/mL) | LOQ c (ng/mL) |
---|---|---|---|---|---|---|---|
1 | Gallic acid | y = 32880.6x − 612.983 | 0.9999718 | 0.48–61.08 | 1.31 | 30 | 100 |
2 | Mangiferin | y = 29263.5x + 13863.9 | 0.9997952 | 0.28–145.00 | 1.32 | 310 | 940 |
3 | Caffeic acid | y = 57646.8x − 3853.48 | 0.9999218 | 0.72–91.92 | 1.56 | 20 | 60 |
4 | Tectoridin | y = 76104.4x + 114152 | 0.9995802 | 0.51–260.00 | 0.55 | 130 | 400 |
5 | Germanaism B | y = 60944.8x + 123042 | 0.9993218 | 0.58–298.00 | 0.46 | 50 | 160 |
6 | Irisolidone |
y = 29507.2x + 5569.89 | 0.999981 | 0.49–63.1 | 0.98 | 30 | 90 |
7 | Iristectorigenin B | y = 109562x + 68062.7 | 0.9996806 | 0.23–120.00 | 0.85 | 50 | 150 |
8 | Nigricin | y = 89415.4x + 103288 | 0.9994037 | 0.35–181.00 | 0.30 | 40 | 130 |
9 | Irigenin | y = 81832.6x + 137668 | 0.9994881 | 0.54–277.00 | 0.64 | 50 | 160 |
10 | 5,6-Dihydroxy-7,8,3′,5′-tetramethoxyisoflavone | y = 86268.5x + 59193.5 | 0.9996879 | 0.26–132.00 | 0.54 | 70 | 210 |
11 | Irisolidone | y = 54297.4x + 9147.67 | 0.999988 | 0.54–69.77 | 1.26 | 10 | 30 |
a compound concentration (mg/mL); y, peak area; b LOD, limit of detection (S/N = 3); c LOQ, limit of quantification (S/N = 10).
Table 2Precision and stability of the eleven quantified compounds.
Peak No. | Compound | Concentration (µg/mL) | Precision | Repeatability | ||||
---|---|---|---|---|---|---|---|---|
Intra-Day (n = 3) | Inter-Day (n = 3) | Recovery (%) | RSD (%) | |||||
RSD (%) | Accuracy (%) | RSD (%) | Accuracy (%) | |||||
1 | Gallic acid | 7.65 | 0.57 | 99.81 | 0.75 | 101.37 | 101.07 | 0.65 |
30.35 | 0.78 | 99.56 | 0.24 | 102.14 | 99.69 | 0.56 | ||
61.20 | 1.02 | 101.53 | 0.38 | 101.32 | 100.09 | 0.94 | ||
2 | Mangiferin | 9.06 | 0.33 | 100.46 | 0.29 | 100.41 | 100.29 | 0.25 |
36.25 | 0.24 | 99.66 | 0.32 | 100.45 | 100.03 | 0.39 | ||
145 | 0.22 | 100.32 | 1.10 | 98.45 | 99.58 | 0.99 | ||
3 | Caffeic acid | 11.49 | 1.05 | 102.02 | 0.52 | 98.49 | 100.01 | 0.46 |
45.96 | 1.08 | 98.78 | 0.67 | 99.73 | 99.39 | 0.99 | ||
91.92 | 0.64 | 100.35 | 0.95 | 98.17 | 100.17 | 0.37 | ||
4 | Tectoridin | 16.25 | 1.35 | 101.93 | 1.57 | 102.24 | 101.39 | 0.98 |
65 | 1.13 | 101.92 | 0.72 | 101.03 | 100.98 | 0.95 | ||
260 | 0.30 | 99.57 | 0.03 | 99.96 | 99.84 | 0.23 | ||
5 | Germanaism B | 18.62 | 0.65 | 100.92 | 0.16 | 100.23 | 100.38 | 0.48 |
74.5 | 1.07 | 101.52 | 1.50 | 102.15 | 101.22 | 0.99 | ||
298 | 0.64 | 99.09 | 0.93 | 98.69 | 99.26 | 0.68 | ||
6 | Irisolidone- |
0.49 | 1.07 | 98.35 | 0.92 | 101.64 | 100.34 | 1.05 |
7.88 | 0.95 | 101.38 | 0.73 | 99.32 | 98.07 | 0.97 | ||
31.55 | 1.02 | 100.44 | 0.94 | 99.78 | 100.74 | 0.31 | ||
7 | Iristectorigenin B | 7.5 | 1.23 | 101.76 | 1.64 | 102.35 | 101.36 | 0.97 |
30 | 1.01 | 102.88 | 1.23 | 101.76 | 101.54 | 1.01 | ||
120 | 0.07 | 99.90 | 0.33 | 99.53 | 99.81 | 0.25 | ||
8 | Nigricin | 11.31 | 1.19 | 101.70 | 1.21 | 101.73 | 101.14 | 0.98 |
45.25 | 0.37 | 99.47 | 1.19 | 101.70 | 100.39 | 0.96 | ||
181 | 0.57 | 99.19 | 0.48 | 99.33 | 99.50 | 0.43 | ||
9 | Irigenin | 17.31 | 1.08 | 101.54 | 1.29 | 101.84 | 101.12 | 0.98 |
69.25 | 0.80 | 101.14 | 1.16 | 101.65 | 100.93 | 0.84 | ||
277 | 0.33 | 99.53 | 0.20 | 99.71 | 99.74 | 0.24 | ||
10 | 5,6-Dihydroxy-7,8,3′,5′-tetrametoxyisoflavone | 8.25 | 0.43 | 100.61 | 0.77 | 101.09 | 100.56 | 0.54 |
33 | 0.06 | 100.08 | 0.52 | 100.74 | 100.27 | 0.41 | ||
132 | 0.18 | 99.74 | 0.80 | 98.88 | 99.54 | 0.59 | ||
11 | Irisolidone | 0.54 | 1.07 | 98.74 | 0.52 | 98.24 | 100.06 | 0.52 |
8.72 | 1.12 | 101.20 | 0.67 | 99.41 | 99.69 | 0.85 | ||
34.88 | 0.42 | 100.29 | 0.95 | 100.86 | 100.77 | 0.20 |
Chromatographic, UV, and mass spectroscopic data of the reference compounds.
Peak No | tR (min) | UV λmax (nm) | Mol. Formula | Calculated m/z | Compound | [M − H]− (m/z) | Fragment Ions (−) |
---|---|---|---|---|---|---|---|
1 | 5.96 | 214, 271 | C7H6O5 | 170.12 | Gallic acid | 169 | 125 |
2 | 14.18 | 240, 318, 257, 365 | C19H18O11 | 422.33 | Mangiferin | 421 | 403, 331, 301, 271 |
3 | 14.48 | 217, 236, 324 | C9H8O4 | 180.16 | Caffeic acid | 179 | 135 |
4 | 29.48 | 263, 328 | C22H22O11 | 462.41 | Tectoridin | 461 | 446, 428, 341, 299 |
5 | 41.08 | 260, 322 | C23H22O11 | 474.42 | Germanaism B | 473 | ND* |
6 | 45.91 | 260, 330 | C23H23O11 | 476.13 | Irisolidone |
475 | 313, 298 |
7 | 49.15 | 218, 265 | C17H14O7 | 330.29 | Iristectorigenin B | 329 | 314, 311, 299, 271, 255, 164 |
8 | 49.50 | 262, 322 | C17H12O6 | 312.28 | Nigricin | 311 | ND* |
9 | 50.03 | 264, 218 | C19H16O8 | 360.32 | Irigenin | 359 | 344, 329, 314, 286, 258 |
10 | 56.03 | 222, 265 | C19H18O8 | 374.35 | 5,6-Dihydroxy-7,8,3′,5′-tetramethoxyisoflavone | 373 | 358, 135 |
11 | 61.24 | 259, 322 | C14H14O6 | 314.08 | Irisolidone | 313 | 298 |
* ND—compound was not detected in the negative ion mode.
Table 4Phenolic compounds content of I. pallida, I. hungarica, I. sibirica, and I. variegata rhizomes (mg/g).
Peak No | Compound | I. pallida | I. hungarica | I. sibirica | I. variegata |
---|---|---|---|---|---|
1 | Gallic acid | - | 2.362 ± 0.076 | - | 3.729 ± 0.134 |
2 | Mangiferin | 0.849 ± 0.029 | 2.368 ± 0.023 | 0.267 ± 0.002 | 5.747 ± 0.080 |
3 | Caffeic acid | 0.227 ± 0.033 | 1.515 ± 0.005 | 0.288 ± 0.012 | 1.236 ± 0.005 |
4 | Tectoridin | 1.642 ± 0.023 | 3.921 ± 0.071 | 0.038 ± 0.001 | 0.989 ± 0.006 |
5 | Germanaism B | 0.534 ± 0.015 | 6.285 ± 0.030 | 0.012 ± 0.000 | 7.089 ± 0.032 |
6 | Irisolidone- |
0.325 ± 0.030 | 7.353 ± 0.025 | 0.115 ± 0.005 | 7.507 ± 0.005 |
7 | Iristectorigenin B | 0.354 ± 0.004 | 0.750 ± 0.003 | - | 0.204 ± 0.005 |
8 | Nigricin | 0.317 ± 0.003 | 2.267 ± 0.003 | 0.079 ± 0.002 | 0.990 ± 0.010 |
9 | Irigenin | 3.199 ± 0.034 | 4.892 ± 0.038 | 0.069 ± 0.000 | 5.518 ± 0.031 |
10 | 5,6-Dihydroxy-7,8,3′,5′-tetramethoxyisoflavone | 0.457 ± 0.003 | 1.056 ± 0.002 | - | 1.512 ± 0.013 |
11 | Irisolidone | 0.264 ± 0.004 | 4.025 ± 0.005 | - | 0.437 ± 0.030 |
Data are expressed as mean ± S.D. For each sample n = 2.
Table 5The radical scavenging activity of individual compounds of I. variegata and I. hungarica extracts expressed as TEAC (µmol/g) using the ABTS post-column assay.
Peak No. | Component | Retention Time | I. variegata Rhizomes Extract (H2O) | I. hungarica Rhizomes Extract (H2O) | I. hungarica Rhizomes Extract (70% EtOH) |
---|---|---|---|---|---|
1 | Gallic acid | 5.78 | 0.52 ± 0.01 | 2.83 ± 0.14 | 3.13 ± 0.14 |
2 | Mangiferin | 12.68 | 2.40 ± 0.06 | 18.01 ± 0.87 | 20.55 ± 1.01 |
3 | Caffeic acid | 15.80 | - | 2.27 ± 0.10 | 26.64 ± 1.28 |
Total | 2.92 ± 0.07 | 23.11 ± 0.90 | 50.32 ± 1.09 |
Anti-inflammatory activity of Iris sp.
Sample Description | Superoxide Anion Generation | Elastase Release |
---|---|---|
Inh% (10 μg/mL) | Inh% (10 μg/mL) | |
I. variegata rhizomes (H2O) | 41.0 ± 0.6 *** | 13.8 ± 5.1 |
I. hungarica rhizomes (H2O) | 45.7 ± 1.4 *** | enhancing a |
I. hungarica rhizomes (70% C2H5OH) | 23.6 ± 1.3 *** | enhancing a |
Percentage of inhibition (Inh%) at 10 μg/mL concentration. Results are presented as mean ± S.E.M. (n = 3). *** p < 0.001 compared with the control (fMLF/CB). Genistein served as the positive control and inhibited 99.7 ± 0.6% of superoxide anion generation at 10 µg/mL and 101.2 ± 6.3% of elastase release at 30 µg/mL. a I. hungarica rhizomes (H2O, 10 μg/mL) and I. hungarica rhizomes (C2H5OH, 10 μg/mL) induced elastase release in the presence of cytochalasin B by 59.6 ± 8.1% and 42.4 ± 7.1%. Results are presented as mean ± S.E.M. (n = 3). Cell responses induced by fMLF/CB were expressed as 100%.
Table 7Antioxidant capacity expressed as NRF2 activity and lipid droplets activity of Iris extracts.
Sample Description | Relative NRF2 Activity a in HacaT Cells b | Lipid Droplet Inhibition Activity c | |
---|---|---|---|
I. variegata rhizomes (H2O) | 172.7 | 95.1 ± 11.6 | |
I. hungarica rhizomes (H2O) | 119.9 | 64.9 ± 8.1 | |
I. hungarica rhizomes (70% C2H5OH) | 130.8 | 101.5 ± 6.8 |
a Relative luciferase activity was calculated by normalizing luciferase activity to cell viability and is presented as the fold to solvent control. b HacaT, a normal skin cell line. The drug concentration was 100 µg/mL. TBHQ, 2-(1,1-dimethylethyl)-1,4-benzenediol (10 µM), was used as the positive control for NRF2 activation and showed 684.3 ± 37.7% of NRF2 activity. c Lipid droplet count. The average lipid droplet counts/cells of oleic acid were used as the standard representing 100% of lipid loading in Huh7 liver cell line, % mean ± S.E.M. Triacsin C (1 µM), an inhibitor of long-chain acyl-CoA synthetase, was used as the positive control and showed 16.3 ± 0.1% of lipid formation.
Table 8Anti-allergic activity of Iris sp.
Sample Description | % Viability, RBL-2H3 a | % Inhibition of A23187-Induced Degranulation b | % Inhibition of Antigen-Induced Degranulation b | |||
---|---|---|---|---|---|---|
100 μg/mL | 10 μg/mL | 100 μg/mL | 10 μg/mL | 100 μg/mL | ||
I. variegata rhizomes (H2O) | 96.3 ± 0.7 | 12.7 ± 0.3 | 38.3 ± 3.5 *** | 10.7 ± 3.3 | 27.0 ± 4.5 * | |
I. hungarica rhizomes (H2O) | 96.7 ± 1.7 | 3.7 ± 3.0 | 3.3 ± 2.0 | 4.0 ± 3.3 | 12.7 ± 1.7 | |
I. hungarica rhizomes (70% C2H5OH) | 96.3 ± 1.9 | 7.3 ± 2.0 | 22.0 ± 5.0 * | 4.7 ± 3.8 | 46.7 ± 2.1 *** |
a The cytotoxicity of samples to RBL-2H3 was evaluated using MTT viability assay. Results are presented as mean ± S.E.M. (n = 3) compared with the untreated control (DMSO). Samples with viability above 85% were considered nontoxic towards RBL-2H3 cells. b Inhibition of the degranulation was assessed by A23187-induced and antigen-induced β-hexosaminidase release in RBL-2H3 cells. Results are presented as mean ± S.E.M. (n = 3); * p < 0.05, ** p < 0.01, *** p < 0.001 (Prism, ANOVA, Dunnet’s test) compared with the control value (A23187 or antigen only). Dexamethasone (10 nM) was used as the positive control and inhibited 65.7 ± 5.4% *** of A23187-induced and 66.3 ± 4.8% *** of antigen-induced degranulation.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© 2020 by the authors.
Abstract
The major groups of antioxidant compounds (isoflavonoids, xanthones, hydroxycinnamic acids) in the rhizome methanol extracts of four Ukrainian Iris sp. (Iris pallida, Iris hungarica, Iris sibirica, and Iris variegata) were qualitatively and quantitatively analyzed using HPLC-DAD and UPLC-MS/MS. Gallic acid, caffeic acid, mangiferin, tectoridin, irigenin, iristectorigenin B, irisolidone, 5,6-dihydroxy-7,8,3′,5′-tetramethoxyisoflavone, irisolidone-7-O-β-
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details







1 Department of Pharmaceutical Chemistry, National University of Pharmacy, 4-Valentinivska st., 61168 Kharkiv, Ukraine;
2 Department of Biotechnology, College of Life Science, Kaohsiung Medical University, Kaohsiung 80708, Taiwan;
3 Department of Analytical and Toxicological Chemistry, Lithuanian University of Health Sciences, A. Mickevičiaus g. 9, LT 44307 Kaunas, Lithuania;
4 Laboratory of Drug Targets Histopathology, Institute of Cardiology, Lithuanian University of Health Sciences, Sukilėlių pr. 13, LT-50162 Kaunas, Lithuania;
5 Department of Pharmaceutical Biology, Faculty of Pharmacy and Biotechnology, the German University in Cairo, Cairo 11835, Egypt;
6 Department of Biochemistry and Molecular Biology, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan;
7 Graduate Institute of Natural Products, College of Pharmacy, Kaohsiung Medical University, Kaohsiung 80708, Taiwan;
8 Department of Biotechnology, College of Life Science, Kaohsiung Medical University, Kaohsiung 80708, Taiwan;
9 Graduate Institute of Natural Products, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan; Research Center for Chinese Herbal Medicine, Research Center for Food and Cosmetic Safety, and Graduate Institute of Health Industry Technology, College of Human Ecology, Chang Gung University of Science and Technology, Taoyuan 33302, Taiwan; Department of Anesthesiology, Chang Gung Memorial Hospital, Taoyuan 33305, Taiwan; Chinese Herbal Medicine Research Team, Healthy Aging Research Center, Chang Gung University, Taoyuan 33302, Taiwan